The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Potential metabolite markers of schizophrenia
Open accessAbstract
Schizophrenia is a severe mental disorder that affects 0.5-1% of the population worldwide. Current diagnostic methods are based on psychiatric interviews, which are subjective in nature. The lack of disease biomarkers to support objective laboratory tests has been a long-standing bottleneck in the clinical diagnosis and evaluation of schizophrenia. Here we report a global metabolic profiling study involving 112 schizophrenic patients and 110 healthy subjects, who were divided into a training set and a test set, designed to identify metabolite markers. A panel of serum markers consisting of glycerate, eicosenoic acid, β-hydroxybutyrate, pyruvate and cystine was identified as an effective diagnostic tool, achieving an area under the receiver operating characteristic curve (AUC) of 0.945 in the training samples (62 patients and 62 controls) and 0.895 in the test samples (50 patients and 48 controls). Furthermore, a composite panel by the addition of urine β-hydroxybutyrate to the serum panel achieved a more satisfactory accuracy, which reached an AUC of 1 in both the training set and the test set. Multiple fatty acids and ketone bodies were found significantly (P<0.01) elevated in both the serum and urine of patients, suggesting an upregulated fatty acid catabolism, presumably resulting from an insufficiency of glucose supply in the brains of schizophrenia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Reactive oxygen species: Metabolism, oxidative stress, and signal transduction
Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723
The use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
McDonald, J. W., & Johnston, M. V. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90011-c · Cited by 1,416
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,170
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Gall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597
Freedman, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035458 · Cited by 587
McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.790 · Cited by 556
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 455
Jonsson, P., Johansson, A. I., Gullberg, J., Trygg, J., A, J., Grung, B., Marklund, S., Sjöström, M., Antti, H., & Moritz, T. (2005) · Analytical Chemistry · doi:10.1021/ac050601e · Cited by 426
Serum Metabolite Profiling of Human Colorectal Cancer Using GC−TOFMS and UPLC−QTOFMS
Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9004162 · Cited by 395
Self-citationTransport of Glutamate and Other Amino Acids at the Blood-Brain Barrier
Smith, Q. R. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1016s · Cited by 381
A Strategy for Identifying Differences in Large Series of Metabolomic Samples Analyzed by GC/MS
Jonsson, P., Gullberg, J., Nordström, A., Kusano, M., Kowalczyk, M., Sjöström, M., & Moritz, T. (2004) · Analytical Chemistry · doi:10.1021/ac0352427 · Cited by 349
n, F. (1943) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-194302000-00025 · Cited by 347
Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 318
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Kaddurah-Daouk, R., & Krishnan, K. R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 293
Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 290
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
Quinones, M. P., & Kaddurah-Daouk, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.019 · Cited by 284
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity
Boudonck, K. J., Mitchell, M. W., Német, L., Keresztes, L., Nyska, A., Shinar, D., & Rosenstock, M. (2009) · Toxicologic Pathology · doi:10.1177/0192623309332992 · Cited by 248
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Fernandez-Egea, E., Bernardo, M., Donner, T., Conget, I., Parellada, E., Justicia, A., Esmatjes, E., Garcia-Rizo, C., & Kirkpatrick, B. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052605 · Cited by 242
Schwarz, E., Prabakaran, S., Whitfield, P., Major, H., Leweke, F. M., Koethe, D., McKenna, P., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 221
Positron Emission Tomography Studies of Abnormal Glucose Metabolism in Schizophrenia
Buchsbaum, M. S., & Hazlett, E. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033331 · Cited by 211
Metabolism of Ketone Bodies by the Brain
Sokoloff, L. (1973) · Annual Review of Medicine · doi:10.1146/annurev.me.24.020173.001415 · Cited by 168
What We Know: Findings That Every Theory of Schizophrenia Should Explain
MacDonald, A. W., & Schulz, S. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp017 · Cited by 165
Cerebral cystine uptake: a tale of two transporters
McBean, G. J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02060-6 · Cited by 164
Permutation Tests for Classification
Golland, P., Liang, F., Mukherjee, S., & Panchenko, D. (2005) · Lecture notes in computer science · doi:10.1007/11503415_34 · Cited by 139
Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134
CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
Huang, J. T.-J., Leweke, F. M., Tsang, T. M., Koethe, D., Kranaster, L., Gerth, C. W., Gross, S., Schreiber, D., Ruhrmann, S., Schultze‐Lutter, F., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000756 · Cited by 128
Increased phospholipase A2 activity in schizophrenia with absent response to niacin
Tavares, H., Yacubian, J., Talib, L. L., Barbosa, N. R., & Gattaz, W. F. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00281-5 · Cited by 125
Abnormal Glucose Metabolism in the Mediodorsal Nucleus of the Thalamus in Schizophrenia
Hazlett, E. A., Buchsbaum, M. S., Kemether, E. M., Bloom, R. F., Platholi, J., Brickman, A. M., Shihabuddin, L., Tang, C. Y., & Byne, W. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.305 · Cited by 124
Yao, J., Dougherty, G. G., Reddy, R. D., Keshavan, M. S., Montrose, D. M., Matson, W. R., Rozen, S., Krishnan, R. R., McEvoy, J. P., & Kaddurah‐Daouk, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.33 · Cited by 118
Metabolic changes in schizophrenia and human brain evolution
Khaitovich, P., Lockstone, H. E., Wayland, M. T., Tsang, T. M., Jayatilaka, S. D., Guo, A. J., Zhou, J., Somel, M., Harris, L. W., Holmes, E. C., et al. (2008) · Genome biology · doi:10.1186/gb-2008-9-8-r124 · Cited by 115
Relative Glucose Metabolic Rate Higher in White Matter in Patients With Schizophrenia
Buchsbaum, M. S., Buchsbaum, B. R., Hazlett, E. A., Haznedar, M. M., Newmark, R. E., Tang, C. Y., & Hof, P. R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1072 · Cited by 104
Neuroimaging in psychiatry: an update
Abou‐Saleh, M. T. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.06.012 · Cited by 90
Glucose-Induced Increase in Memory Performance in Patients With Schizophrenia
Newcomer, J. W., Craft, S., Fucetola, R. P., Moldin, S. O., Selke, G., Paras, L., & Miller, R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033381 · Cited by 81
Miller, A. L., Hawkins, R. A., & Veech, R. L. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb04367.x · Cited by 79
Yao, J. K., Dougherty, G. G., Reddy, R. D., Keshavan, M. S., Montrose, D. M., Matson, W. R., McEvoy, J. P., & Kaddurah‐Daouk, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009508 · Cited by 77
Advances in Proximal Fluid Proteomics for Disease Biomarker Discovery
Teng, P.-N., Bateman, N. W., Hood, B. L., & Conrads, T. P. (2010) · Journal of Proteome Research · doi:10.1021/pr100904q · Cited by 73
Fatty acid compositions of red blood cell phospholipids in children with autism
Bu, B., Ashwood, P., Harvey, D., King, I. B., de Water, J. V., & Jin, L. W. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.02.001 · Cited by 66
Schizophrenia: a biochemical disorder?
Df, H. (1980) · PubMed · Cited by 62
THE NIACIN SKIN FLUSH TEST IN SCHIZOPHRENIA: A REPLICATION STUDY
Puri, B. K., Easton, T., Das, I., Kidane, L., & Richardson, A. J. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11065.x · Cited by 61
Tsang, T. M., Huang, J. T.-J., Holmes, E. C., & Bahn, S. (2006) · Journal of Proteome Research · doi:10.1021/pr0503782 · Cited by 61
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 42
Niacin skin flushing in schizophrenic and depressed patients and healthy controls
Haandel, L. B.-V., Knegtering, R., Kluiter, H., & van den Bosch, R. J. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.10.010 · Cited by 41
Olsen, L., Hansen, T. F., Jakobsen, K. D., Djurovic, S., Melle, I. S., Agartz, I., Hall, H., Ullum, H., Timm, S., Wang, A. G., et al. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-39 · Cited by 39
Proteomics: Advances in Biomarker Discovery
Cowan, M. L., & Vera, J. H. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.1.21 · Cited by 31
Zyromski, N. J., Mathur, A., Gowda, G. A. N., Murphy, C. J., Swartz‐Basile, D. A., Wade, T. E., Pitt, H. A., & Raftery, D. (2009) · Pancreatology · doi:10.1159/000199436 · Cited by 31
Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
Kaddurah‐Daouk, R., Soares, J. C., & Quinones, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_6 · Cited by 9
Cited by
Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8317 · Cited by 704
Urinary Biomarkers of Brain Diseases
An, M., & Gao, Y. (2015) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.08.005 · Cited by 142
Impaired membrane lipid homeostasis in schizophrenia
Li, M., Gao, Y., Wang, D., Hu, X., Jiang, J., Qing, Y., Yang, X., Cui, G., Wang, P., Zhang, J., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac011 · Cited by 63
Self-citationZheng, P., Chen, J.-J., Zhou, C.-J., Zeng, L., Li, K.-W., Sun, L., Liu, M.-L., Zhu, D., Liang, Z.-H., & Xie, P. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.188 · Cited by 60
Self-citationImpaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients
Fournier, M., Ferrari, C., Baumann, P. S., Polari, A., Monin, A., Bellier-Teichmann, T., Wulff, J., Pappan, K. L., Cuenod, M., Conus, P., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu053 · Cited by 48
Metadata
- Authors
- Yang, J., Chen, T., Sun, L., Zhao, Z., Qi, X., Zhou, K., Cao, Y., Wang, X., Qiu, Y., Su, M., Zhao, A., Wang, P., Yang, P., Wu, J., Feng, G., He, L., Jia, W., & Wan, C.
- Venue
- Molecular Psychiatry
- Published
- 2011-10-25
- Volume
- 18
- Issue
- 1
- Pages
- 67-78
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1978876811
- Cited by
- 253
- References
- 58
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.